Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04609683 · ClinicalTrials.gov registry record · NA
Measuring Hydration Levels of Healthy and Heart Failure Patients Before, During, and After an Electrophysiology (EP) Procedure
A NA study of Cardiac Arrhythmia, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT04609683 is a NA study of Cardiac Arrhythmia that has completed, run by NYU Langone Health. The registered enrollment target is 19 participants, below the 212-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04609683, a NA study of Cardiac Arrhythmia, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
Subjects will be consented to wear the AleriTM sensor prior to, during, and after an Electrophysiology Procedure. During this time, the system will measure the following parameters from subjects: HR, temperature, saline volume/rate, urine production volume, USG, BPO. Data will be retrospectively analyzed to determine if the system effectively operates under these conditions, and can effectively monitor hydration levels of subjects compared to currently available methods.
Conditions Studied
Interventions
- DEVICE AleriTM sensors
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2022-09-19 |
| Est. Completion | 2023-11-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04609683
The ClinicalTrials.gov registry entry for NCT04609683 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 212-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (91% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiac Arrhythmia appearing as the primary indexed condition, and to 1 intervention - of which AleriTM sensors is the first listed.
NCT04609683 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04609683 about?
NCT04609683 is a clinical study titled "Measuring Hydration Levels of Healthy and Heart Failure Patients Before, During, and After an Electrophysiology (EP) Procedure". Subjects will be consented to wear the AleriTM sensor prior to, during, and after an Electrophysiology Procedure. During this time, the system will measure the following parameters from subjects: HR, temperature, saline volume/rate, urine production volume, USG, BPO. Data will be retrospectively ana...
What is the current status of trial NCT04609683?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2022-09-19. Estimated completion is 2023-11-05.
What conditions does trial NCT04609683 study?
This clinical trial studies the following conditions: Cardiac Arrhythmia.
What interventions are being tested in trial NCT04609683?
The interventions under investigation include: AleriTM sensors (DEVICE).
Who is sponsoring clinical trial NCT04609683?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04609683 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrhythmia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II
ACTIVE NOT RECRUITING · NA
-
AV Delay Optimization vs. Intrinsic Conduction in Pacemaker Patients With Long PR Intervals
COMPLETED · NA
-
Evaluating Myocardial Injury for Defibrillation Threshold Testing Methods for ICD Implantation
COMPLETED · NA
-
SJM MRI Diagnostic Imaging Registry (IDE)
COMPLETED · NA
-
Maestro Handheld Cardiac Monitor Validation
COMPLETED · NA
-
RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.